Hematopoietic and Lymphoid Cell Neoplasm

Hematopoietic and Lymphoid Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

18,680 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 651–700 of 18,680 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03953898	Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation	active not recruiting	Phase 2	14	National Cancer Institute (NCI)NIH	1	Sep 10, 2026	clinicaltrials
NCT04169737	Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma	recruiting	Phase 2	168	M.D. Anderson Cancer CenterOTHER	1